https://www.auntminnie.com/clinical-news/molecular-imaging/nuclear-medicine/article/15637337/pet-reveals-patient-responses-to-new-alzheimers-disease-drug
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab.
Create an account or login to join the discussion